• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老:细胞清除和癌症之路上的一个程序。

Senescence: A program in the road to cell elimination and cancer.

机构信息

Laboratory of Enzymatic Degradation of Organic Compounds, G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms of RAS, Federal Research Center, Pushchino Center for Biological Research of the Russian Academy of Sciences, Prospekt Nauki 5, Pushchino, Moscow Region, 142290, Russia.

Department of Biochemistry and Molecular Medicine and CRCHUM, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Québec, H3C 3J7, Canada.

出版信息

Semin Cancer Biol. 2022 Jun;81:48-53. doi: 10.1016/j.semcancer.2020.12.017. Epub 2020 Dec 26.

DOI:10.1016/j.semcancer.2020.12.017
PMID:33359514
Abstract

Senescence is a tumor suppressor response that prevents the proliferation of mutated cells and alert the immune system for their elimination. However, this program is not perfect and with time additional genetic and epigenetic changes can impair tumor suppression and promote cancer progression both in cell autonomous and non-cell autonomous manners. A polyploid barrier is implemented in senescent cells to further prevent cell expansion but polyploid cells can generate highly malignant tumor cells via de-polyploidization. The nuclear lamina can act as an additional fail safe to prevent cancer in these cells and drugs able to stabilize the nuclear lamina may help to treat cancers by preventing senescence escape.

摘要

衰老(Senescence)是一种肿瘤抑制反应,可防止突变细胞的增殖,并激活免疫系统将其清除。然而,该程序并不完美,随着时间的推移,其他遗传和表观遗传变化可能会损害肿瘤抑制作用,并以细胞自主和非细胞自主的方式促进癌症进展。衰老细胞中实施了多倍体障碍(polyploid barrier)以进一步防止细胞扩张,但多倍体细胞可以通过去多倍体化(de-polyploidization)产生高度恶性的肿瘤细胞。核纤层(nuclear lamina)可以作为额外的失效保护装置,以防止这些细胞发生癌变,而能够稳定核纤层的药物可能有助于通过防止衰老逃逸来治疗癌症。

相似文献

1
Senescence: A program in the road to cell elimination and cancer.衰老:细胞清除和癌症之路上的一个程序。
Semin Cancer Biol. 2022 Jun;81:48-53. doi: 10.1016/j.semcancer.2020.12.017. Epub 2020 Dec 26.
2
Polyploidy: the link between senescence and cancer.多倍体:衰老与癌症之间的联系。
Curr Pharm Des. 2010;16(6):734-40. doi: 10.2174/138161210790883714.
3
Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.靶向肿瘤细胞衰老和多倍体化为潜在的治疗策略。
Semin Cancer Biol. 2022 Jun;81:37-47. doi: 10.1016/j.semcancer.2020.12.010. Epub 2020 Dec 20.
4
Therapy-induced polyploidization and senescence: Coincidence or interconnection?诱导多倍体化和衰老:巧合还是相互关联?
Semin Cancer Biol. 2022 Jun;81:83-95. doi: 10.1016/j.semcancer.2020.11.015. Epub 2020 Dec 1.
5
The role of autophagy in escaping therapy-induced polyploidy/senescence.自噬在逃避治疗诱导的多倍体/衰老中的作用。
Adv Cancer Res. 2021;150:209-247. doi: 10.1016/bs.acr.2021.01.004. Epub 2021 Mar 11.
6
Therapy-Induced Senescent/Polyploid Cancer Cells Undergo Atypical Divisions Associated with Altered Expression of Meiosis, Spermatogenesis and EMT Genes.治疗诱导的衰老/多倍体癌细胞经历与减数分裂、精子发生和 EMT 基因表达改变相关的非典型分裂。
Int J Mol Sci. 2022 Jul 27;23(15):8288. doi: 10.3390/ijms23158288.
7
Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells.逃避阿霉素诱导的乳腺癌细胞衰老/多倍体化的自噬通量增加。
Int J Mol Sci. 2020 Aug 24;21(17):6084. doi: 10.3390/ijms21176084.
8
Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities.多倍体巨癌细胞中自噬的最新进展及其与衰老和干性的相互关系以寻找治疗机会。
Cancer Lett. 2024 May 28;590:216843. doi: 10.1016/j.canlet.2024.216843. Epub 2024 Apr 4.
9
Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes.在人类浸润性乳腺癌中检测细胞衰老可区分不同的乳腺肿瘤亚型。
Oncotarget. 2016 Nov 15;7(46):74846-74859. doi: 10.18632/oncotarget.12432.
10
Morphological and Functional Characteristic of Senescent Cancer Cells.衰老癌细胞的形态学和功能特征
Curr Drug Targets. 2016;17(4):377-87. doi: 10.2174/1389450116666151019094724.

引用本文的文献

1
Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer.头颈部癌基于衰老的治疗的未来展望
Cancers (Basel). 2025 Jun 12;17(12):1965. doi: 10.3390/cancers17121965.
2
Polyploid giant cancer cells: origin, possible pathways of formation, characteristics, and mechanisms of regulation.多倍体巨癌细胞:起源、可能的形成途径、特征及调控机制
Front Cell Dev Biol. 2024 Jul 11;12:1410637. doi: 10.3389/fcell.2024.1410637. eCollection 2024.
3
Therapy-induced senescence is finally escapable, what is next?诱导性衰老终究是可以逃避的,那么接下来呢?
Cell Cycle. 2024 Mar;23(6):713-721. doi: 10.1080/15384101.2024.2364579. Epub 2024 Jun 16.
4
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review).衰老微环境介导淋巴细胞癌发生和淋巴瘤耐药性:从机制到临床治疗(综述)。
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5653. Epub 2024 May 17.
5
The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy.衰老微环境对肿瘤发生的影响:癌症治疗的新视角。
Aging Cell. 2024 May;23(5):e14182. doi: 10.1111/acel.14182. Epub 2024 Apr 22.
6
Drug repurposing for cancer therapy.药物重用于癌症治疗。
Signal Transduct Target Ther. 2024 Apr 19;9(1):92. doi: 10.1038/s41392-024-01808-1.
7
The senescence journey in cancer immunoediting.癌症免疫编辑中的衰老历程。
Mol Cancer. 2024 Apr 1;23(1):68. doi: 10.1186/s12943-024-01973-5.
8
Autophagy and Senescence: The Molecular Mechanisms and Implications in Liver Diseases.自噬与衰老:在肝脏疾病中的分子机制及意义。
Int J Mol Sci. 2023 Nov 28;24(23):16880. doi: 10.3390/ijms242316880.
9
An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma.衰老肿瘤细胞的一种免疫抑制亚型预示着肺腺癌患者的免疫治疗反应较差。
iScience. 2023 Sep 9;26(10):107894. doi: 10.1016/j.isci.2023.107894. eCollection 2023 Oct 20.
10
What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?癌症治疗持续失败的原因是什么?是误导性/不适当的临床前检测方法应该受到指责吗?一些现代疗法会不会弊大于利?
Int J Mol Sci. 2022 Oct 30;23(21):13217. doi: 10.3390/ijms232113217.